Facile Colorimetric Determination of Duloxetine in Formulations Using Methyl Orange as Ion-Pairing Agent
Purpose: To develop a new and fully validated ion-pair spectrophotometric method for the determination of duloxetine hydrochloride (DX).
Methods: Ion-pair spectrophotometric method was employed for the determination of duloxetine hydrochloride (DX) in bulk and pharmaceutical formulations using acidic dye methyl orange (MO) as ion-pairing agent at pH 4 (phthalate buffer). The yellow ion-pair complex was extracted with chloroform and spectrophotometrically estimated at 420 nm. The developed method was validated according to ICH and USP guidelines.
Results: The ion-pair complex of DX and MO obeyed Beer’s law in the range of 2 - 20 g mL-1 of DX with a correlation coefficient of 0.998. Recovery was good, with a relative standard deviation (%RSD) of 0.88 - 1.02; precision (inter-day, 0.878 and intra-day, 0.921) was also within validation limits. The limit of detection (LOD) and limit of quantitation (LOQ) were 0.25 and 4 g mL-1, respectively. The method developed was successfully applied to determine DX in a formulation.
Conclusion: The developed method is accurate, precise, rugged, robust and reproducible. It is also sensitive and specific for the determination of DX in bulk and formulation.
Keywords: Duloxetine, Methyl orange, Ion-pair, Validation, Spectrophotometry
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.